Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Sung-Bae Kim"'
Autor:
Bhumsuk Keam, Keon Uk Park, Hye Ryun Kim, Keun-Wook Lee, Sung-Bae Kim, Seong Hoon Shin, Jin-Hyuk Choi, Eun Joo Kang, Yun-Gyoo Lee, Hyo Jung Kim, Min Kyoung Kim, Hwan Jung Yun, Kyoung Eun Lee, Jin-Soo Kim, Hee Kyung Ahn
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose Certain patient subgroups who do not respond to induction chemotherapy (IC) show inherent chemoresistance in locally advanced head and neck squamous cell carcinoma (LA-HNSCC). This study aimed to assess the prognostic value of IC, and role of
Autor:
Jaekyung Cheon, Jin-Hee Ahn, Keun Seok Lee, Joohyuk Sohn, In Hae Park, Gun Min Kim, Jeong Eun Kim, Sung-Bae Kim, Jae Ho Jeong, Su-Jin Koh, Sung Hoon Sim, Kyung Hae Jung
Publikováno v:
European Journal of Cancer. 144:341-350
Purpose In the randomised phase II LEO trial, we investigated the effect of adding everolimus (EVE) to letrozole (LET) in ovarian-suppressed premenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2–) recurrent/metastatic breast
Autor:
Ji Yong Ahn, Gin Hyug Lee, Jihoon Kang, Ho June Song, Jonghoon Kim, Do Hoon Kim, Jin-Sook Ryu, Kyung-Ja Cho, Hyeong Ryul Kim, Kee Don Choi, Han Pil Lee, Mi-Yeon Lee, Sung-Bae Kim, Sook Ryun Park, Yong-Hee Kim, Hwoon-Yong Jung
Publikováno v:
Surgical Oncology. 35:491-497
The American Joint Committee on Cancer 8th edition staging system presents separate classifications for pTNM and post-neoadjuvant ypTNM (ypTNM-8th) to enhance prognostic prediction after neoadjuvant therapy and surgery. We aimed to validate the ypTNM
Autor:
Sung-Bae Kim, Yeon Joo Kim, Beom Seok Ko, Kyung Hae Jung, Jin-Hee Ahn, Jong Won Lee, Eun Kyung Choi, Sei Hyun Ahn, Su Ssan Kim, Jinhong Jung, Byung Ho Son, Seung Do Ahn, Hee Jeong Kim, Jeong Eun Kim
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 17:495-505
Aim This study was undertaken to investigate the role of postoperative radiotherapy (PORT) including post-breast conserving radiotherapy (PBCRT) and post-mastectomy radiotherapy (PMRT) in stage IV breast cancer patients who underwent planned primary
Autor:
Hee Kyung Ahn, Eun Joo Kang, Seong Hoon Shin, Sung-Bae Kim, Y. Lee, Keon Uk Park, Jung Hye Kwon, Kyoung Eun Lee, Keun Wook Lee, Hwan Jung Yun, Hye Ryun Kim, Min Kyoung Kim, Jin-Soo Kim, Jin-Hyuk Choi, Bhumsuk Keam
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Cancer
BMC Cancer
Background By investigating treatment patterns and outcomes in locally advanced head and neck squamous cell carcinoma (LA-HNSCC), we aimed at providing valuable insights into the optimal therapeutic strategy for physicians in real-world practice. Met
Autor:
Bo Zhang, Kenichi Inoue, Binghe Xu, Louis W.C. Chow, JuRueyJiuan Lee, Richard Bryce, Sung-Bae Kim
Publikováno v:
Future Oncology. 15:3243-3253
Aim: To evaluate the safety and efficacy of neratinib-based therapy in Asian patients with HER2-positive metastatic breast cancer (MBC). Patients & methods: We performed a pooled analysis of seven early-phase studies of neratinib given either as mono
Autor:
Jesang Yu, Jong Hoon Kim, Sung-Bae Kim, Sook Ryun Park, Young-Hee Kim, Hyeong Ryul Kim, Hyun Joo Lee, Ho June Song, Kye Jin Song, Jeong Yun Jang, Yoon Young Jo, Ye Jin Yoo
Publikováno v:
Cancer Research & Treatment; Oct2022, Vol. 54 Issue 4, p1148-1156, 9p
Autor:
Seock-Ah Im, Annabel Goodwin, Joohyuk Sohn, Kyung-Hun Lee, Sung-Bae Kim, Silvana Lanzalone, Tiziana Usari
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose We evaluated study outcomes in patients enrolled in Asian regions in the phase III EMBRACA trial of talazoparib vs. chemotherapy. Materials and methods Patients with human epidermal growth factor receptor 2-negative germline BRCA1/2-mutated a
Autor:
Hak Hee Kim, Gyungyub Gong, Hee Jeong Kim, Jing Han, Jisun Kim, Hyun Ho Han, Saebyeol Lee, Sung-Bae Kim, Sei Hyun Ahn, Jongwon Lee, BeomSeok Ko, Jin Sup Eom, Zhen-Yu Wu, Byung-Ho Son, Il Yong Chung
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 47(6)
There are limited available data on the prognostic implications of locoregional recurrence (LRR) after nipple-sparing mastectomy (NSM) and immediate reconstruction. In this study, we investigated the patterns and prognosis associated with LRR followi
Autor:
Gyungyub Gong, Jisun Kim, Jongwon Lee, Sae-Byul Lee, Jin-Sup Eom, BeomSeok Ko, Byung-Ho Son, Hak Hee Kim, Sung-Bae Kim, Hee Jeong Kim, Kyung Hae Jung, Sei Hyun Ahn, Zhen-Yu Wu, Il-Yong Chung
Publikováno v:
JAMA Surg
Importance An increasing number of patients with breast cancer receiving neoadjuvant chemotherapy (NACT) undergo immediate breast reconstruction (IBR) with nipple-sparing mastectomy (NSM) or skin-sparing mastectomy (SSM) as surgical treatment. Howeve